194 related articles for article (PubMed ID: 26942732)
1. Vancomycin Pharmacokinetic Parameters in Patients with Hemorrhagic Stroke.
Morbitzer KA; Jordan JD; Sullivan KA; Durr EA; Olm-Shipman CM; Rhoney DH
Neurocrit Care; 2016 Oct; 25(2):250-7. PubMed ID: 26942732
[TBL] [Abstract][Full Text] [Related]
2. Enhanced renal clearance and impact on vancomycin pharmacokinetic parameters in patients with hemorrhagic stroke.
Morbitzer KA; Rhoney DH; Dehne KA; Jordan JD
J Intensive Care; 2019; 7():51. PubMed ID: 31832200
[TBL] [Abstract][Full Text] [Related]
3. The association of elevated trough serum vancomycin concentrations with obesity.
Richardson J; Scheetz M; O'Donnell EP
J Infect Chemother; 2015 Jul; 21(7):507-11. PubMed ID: 25851852
[TBL] [Abstract][Full Text] [Related]
4. A randomized controlled trial of a vancomycin loading dose in children.
Demirjian A; Finkelstein Y; Nava-Ocampo A; Arnold A; Jones S; Monuteaux M; Sandora TJ; Patterson A; Harper MB
Pediatr Infect Dis J; 2013 Nov; 32(11):1217-23. PubMed ID: 23817340
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Capping Creatinine Clearance on Achieving Therapeutic Vancomycin Concentrations in Neurocritically Ill Patients with Traumatic Brain Injury.
Nelson NR; Morbitzer KA; Jordan JD; Rhoney DH
Neurocrit Care; 2019 Feb; 30(1):126-131. PubMed ID: 30051194
[TBL] [Abstract][Full Text] [Related]
6. Concordance of Vancomycin Population-Predicted Pharmacokinetics with Patient-Specific Pharmacokinetics in Adult Hospitalized Patients: A Case Series.
Onor IO; Neuliep A; Tran KA; Lambert J; Gillard CJ; Brakta F; Ezebuenyi MC; St James K; Okogbaa JI; Beyl RA
Drugs R D; 2020 Jun; 20(2):83-93. PubMed ID: 32166646
[TBL] [Abstract][Full Text] [Related]
7. Individualized Pharmacokinetic Dosing of Vancomycin Reduces Time to Therapeutic Trough Concentrations in Critically Ill Patients.
Truong J; Smith SR; Veillette JJ; Forland SC
J Clin Pharmacol; 2018 Sep; 58(9):1123-1130. PubMed ID: 29957824
[TBL] [Abstract][Full Text] [Related]
8. Vancomycin pharmacokinetic parameters in patients with acute brain injury undergoing controlled normothermia, therapeutic hypothermia, or pentobarbital infusion.
Morbitzer KA; Jordan JD; Rhoney DH
Neurocrit Care; 2015 Apr; 22(2):258-64. PubMed ID: 25330755
[TBL] [Abstract][Full Text] [Related]
9. Pediatric Assessment of Vancomycin Empiric Dosing (PAVED): a Retrospective Review.
Rainkie D; Ensom MH; Carr R
Paediatr Drugs; 2015 Jun; 17(3):245-53. PubMed ID: 25813682
[TBL] [Abstract][Full Text] [Related]
10. Predictive Performance of Vancomycin Trough Concentrations in Patients With Diabetes With Microalbuminuria.
Kimura H; Shigematsu M; Tanaka A; Watanabe S; Takatori S; Tanaka M; Mizuma T; Araki H
Ther Drug Monit; 2017 Dec; 39(6):614-616. PubMed ID: 28976419
[TBL] [Abstract][Full Text] [Related]
11. Vancomycin population pharmacokinetics in neonates.
de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
Clin Pharmacol Ther; 2000 Apr; 67(4):360-7. PubMed ID: 10801244
[TBL] [Abstract][Full Text] [Related]
12. Methodological Study of Vancomycin Dosing in Elderly Patients Using Actual Serum Creatinine Versus Rounded Serum Creatinine.
Young T; Daniel M; Baumhover S; Eidson D; Green J
Drugs R D; 2017 Sep; 17(3):435-440. PubMed ID: 28815425
[TBL] [Abstract][Full Text] [Related]
13. A Randomized Pharmacokinetic and Pharmacodynamic Evaluation of Every 8-Hour and 12-Hour Dosing Strategies of Vancomycin and Cefepime in Neurocritically ill Patients.
Kassel LE; Van Matre ET; Foster CJ; Fish DN; Mueller SW; Sherman DS; Wempe MF; MacLaren R; Neumann RT; Kiser TH
Pharmacotherapy; 2018 Sep; 38(9):921-934. PubMed ID: 29906310
[TBL] [Abstract][Full Text] [Related]
14. Assessment of vancomycin dosing and subsequent serum concentrations in pediatric patients.
Eiland LS; English TM; Eiland EH
Ann Pharmacother; 2011 May; 45(5):582-9. PubMed ID: 21521865
[TBL] [Abstract][Full Text] [Related]
15. [Predictive performance of population pharmacokinetic software on vancomycin steady-state trough concentration].
Xue S; Lu H; Tang L; Fang J; Shi L; Li J; Yu Y; Zhou Q; Xue S
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Jan; 32(1):50-55. PubMed ID: 32148231
[TBL] [Abstract][Full Text] [Related]
16. Desired vancomycin trough serum concentration for treating invasive methicillin-resistant Staphylococcal infections.
Frymoyer A; Guglielmo BJ; Hersh AL
Pediatr Infect Dis J; 2013 Oct; 32(10):1077-9. PubMed ID: 23652479
[TBL] [Abstract][Full Text] [Related]
17. Correlation of a Vancomycin Pharmacokinetic Model and Trough Serum Concentrations in Pediatric Patients.
Ploessl C; White C; Manasco K
Pediatr Infect Dis J; 2015 Oct; 34(10):e244-7. PubMed ID: 26121203
[TBL] [Abstract][Full Text] [Related]
18. Individualized vancomycin dosing in obese patients: a two-sample measurement approach improves target attainment.
Hong J; Krop LC; Johns T; Pai MP
Pharmacotherapy; 2015 May; 35(5):455-63. PubMed ID: 26011138
[TBL] [Abstract][Full Text] [Related]
19. The pharmacokinetics of vancomycin in patients with severe acute pancreatitis.
He J; Mao EQ; Feng J; Jiang HT; Yang WH; Chen EZ
Eur J Clin Pharmacol; 2016 Jun; 72(6):697-702. PubMed ID: 26902230
[TBL] [Abstract][Full Text] [Related]
20. An evaluation of vancomycin dosing for complicated infections in pediatric patients.
Durham SH; Simmons ML; Mulherin DW; Foland JA
Hosp Pediatr; 2015 May; 5(5):276-81. PubMed ID: 25934812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
